Login

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer Age 2024 pay Source
Natalie Holles Also a director
CEO
Title from the Form 4 dated Aug 11, 2025
52 $4,157,389
Christopher M. Murphy
Chief Financial & Bus. Officer
Title from the Form 4 dated Aug 11, 2025
Not stated $4,022,334

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
0 of 1
stated in the proxy; 6 not stated
Average tenure
4.2 years
from year joined
CEO also chairs the board
No
Mark Iwicki
Director Age On board Independent Committees Other public boards 2024 pay Source
Mark Iwicki
58 Not stated Not stated
Compensation Committee · Chair
Merus N.V. $280,144
Natalie Holles
52 2021
4 years
Not independent None stated None stated Paid as CEO
Thomas M. Soloway
58 2022
3 years
Not stated
Audit Committee · Chair Nominating and Governance Committee
None stated $259,144
David Bonita, M.D.
49 2020
5 years
Not stated
Compensation Committee
Acutus Medical, Inc., Ikena Oncology, Inc., Prelude Therapeutics, Inc., Repare Therapeutics Inc. $245,144
Geoff McDonough, M.D.
54 2024
1 year
Not stated
Audit Committee Nominating and Governance Committee
None stated $451,977
Michael Gladstone
38 2019
6 years
Not stated
Compensation Committee
Day One Biopharmaceuticals, Inc., Diagonal Therapeutics, Inc., Pheon Therapeutics Inc., Aiolos Bio, Inc. $245,144
H. Martin Seidel, Ph.D.
60 2019
6 years
Not stated
Audit Committee Nominating and Governance Committee · Chair
None stated $253,906

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 25, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support